The World Vaccine Congress’ Post

Good news from the U.S. Department of Health and Human Services (HHS) – ASPR has released the new Pandemic Influenza Preparedness and Response Strategy in response to the threat of H5N1 bird flu in humans. The Task Force for Global Health, Inc.'s Partnership for International Vaccine Initiatives (PIVI) supports these efforts to enhance vaccine systems by increasing stockpiles, developing novel vaccines, and improving diagnostics. Planning ahead is key to pandemic readiness. Read more about the strategy ➡️ https://bit.ly/4eIjjsk. Learn more about PIVI ➡️ pivipartners.org #InfluenzaVaccine #PandemicPreparedness

Prime is excited to attend the upcoming ESCMID Global conference, taking place 27–30 April in Barcelona. This event is a critical platform for sharing and advancing accurate information in the field of microbiology and infectious diseases. At Prime, we recognize that accurate information is essential , especially in the context of vaccination. The spread of misinformation and vaccine hesitancy poses a serious threat to public health, as highlighted by the World Health Organization. Vaccination remains one of the most effective tools in preventing infectious diseases. By participating in events like ESCMID Global, Prime aims to contribute to the dissemination of credible scientific knowledge. We believe that fostering a deeper understanding of vaccines and infectious diseases through accurate information is key to building trust in public health interventions. Join us at ESCMID Global to explore how we can work together to combat misinformation, promote evidence-based practices, and strengthen global health efforts. Together, let's advocate for #HealthEducation and #TrustInScience. #VaccinesWork #HealthEducation #TrustInScience #ESCMIDGlobal #ECCMID2024

Today I had a fantastic conversation with the inspiring Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, at Clinton Global Initiative about AMR. At PATH, we recognize AMR as a global threat, claiming an estimated 1.27 million lives in 2019. Climate change and other crises are further exacerbating this issue. That's why PATH advocates for a One Health approach, acknowledging the interconnectedness of human, animal, and environmental health. Prevention is key. Vaccines remain one of our most effective tools, and PATH's Center for Vaccine Innovation and Access (CVIA) has been a leader in global immunization efforts for decades. Additionally, strengthening of diagnostics and surveillance is crucial to track resistance patterns and enable rapid responses. Governments, global organizations, and private sector must partner and come together with communities to: Strengthen immunization and diagnostics Invest in new antibiotic research Secure sustained funding for AMR prevention and response Address antibiotics misuse across sectors Now during #UNGA79, I'm feeling energized and optimistic that we can tackle AMR together - and safeguard global health for future generations. Read more about PATH's call to action: https://lnkd.in/gMhNQxPi

With the number of cholera cases and outbreaks surging, we need to be able to manufacture more oral cholera vaccine (OCV). Working with the Gates Foundation and EuBiologics, IVI has helped to develop a simplified OCV (Euvichol-S). The simplified OCV is non-inferior to the older version, but can be made in larger quantities for a lower price. This also has the benefit of making the vaccine easier to technology transfer (and work to tech transfer OCV-S to other companies is ongoing). With the stockpile of OCV depleted, the demand for vaccine increasing, and with an official reduction from two doses to a single dose because of the shortage of OCV, IVI and its partners are working from innovation to impact, lowering cost, increasing supply, and supporting regional manufacturing initiatives!

Bird flu is yet another wake-up call: we are not prepared for another pandemic. It is time for a new approach to infectious disease innovation that incentivizes solving the most pressing health issues of our day. We need to fast-track discoveries from the lab into approved diagnostics, therapies and vaccines. We need mission-driven science. Texas Biomed President/CEO Larry Schlesinger, M.D., shares how mission-driven science can ensure we don't miss our window of opportunity to save lives in Texas Monthly: #oped #opinion #solutions #infectiousdiseases #birdflu https://lnkd.in/gUcbkAXN

[#FRIDAYREAD] 📰 Discover the updated protocol published this week on European Centre for Disease Prevention and Control (ECDC) website : "Protocol for a COVID-19 vaccine effectiveness estimation using health data registries, VEBIS multi-country study - Version 2.0" Epiconcept co-authors : Baltazar Nunes, Anthony Nardone, Alexis Sentís Fuster, Esther Kissling, James Humphreys Part of the Executive Summary: "This work is performed within the Vaccine Effectiveness, Burden and Impact Studies (VEBIS) project. The first objective of the study is to monitor COVID-19 VE in a prospective manner, with the production of VE monthly pooled estimates from up to eight countries, including Denmark, Spain (Navarre region only), Norway, Portugal, and Belgium from October 2023 to July 2024. The present master protocol (version 2.0) intends to update the previously used methods [2] to monitor COVID-19 VE to reflect on the current SARS-CoV-2 testing strategies and 2023 autumn vaccination recommendations that now target specific age groups." Discover the full protocol 👇 https://lnkd.in/e_viDthn #VaccineEffectiveness #Covid19 #VEBIS

During 2020, the year when the SARS-CoV-2 pandemic first raged in Germany, researchers raced against time to get to know the virus, the symptoms it caused and the antibodies it elicited. P95 , together with CureVac SE, conducted one of these observational studies – at Universitätsmedizin Mainz. The results of this study, coauthored by Thomas Verstraeten, Wendy Hartig-Merkel, Thao Mai Phuong Tran and Omar Okasha, MD, MPH, are available below. #research #covid #infectiousdiseases #pandemic #observationalstudy https://lnkd.in/erqYy7yC

Are you experiencing side effects from the Covid vaccine and wondering if it could be acting as an immunosuppressant? Watch Full video here: https://lnkd.in/gezqZCRp In this video, we delve into the topic to explore whether the Covid vaccine could be making us sick by suppressing our immune system. Watch to understand the potential immunosuppressant effects of the Covid vaccine and how it may impact your health. Stay informed and empowered with the facts! Jung, Seung-Won, et al. "Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study." Nature Communications 15.1 (2024): 6181. https://lnkd.in/gJQvCykU ========================================================== Navigating the Covid STORM – Therapeutic Options Webinar - Thursday 8th August, 2024 at 7PM UK time https://lnkd.in/gHsRKseX ========================================================== Get the FREE ebook here! Explaining the science around humming, nitric oxide and the sinuses. https://lnkd.in/gkjW3zT7 ========================================================== A New Covid STORM – Recognize It or Risk the Consequences https://lnkd.in/gu32qZ_T #covid #medicine #research

📢 Our new Vaccines and Public Health business unit came together at a 2 day offsite last week! We celebrated our 130-year legacy, recapping our pioneering history in researching and developing vaccines and treatments to tackle infectious disease. Vaccines and antimicrobials are integral components of #PublicHealth management strategies that contribute to disease prevention, control, and the overall health security of the nation. Our whole team is motivated by the prospect of disease elimination and are actively partnering to eliminate cervical cancer, measles, and hepatitis C in the UK, ensuring that regardless of background, no one is left behind. Here are 3 things that I learnt from a fabulous 2 days with the team: ·      The importance of #partnerships - As facilitators of positive change, we're working to accelerate innovative ways of delivering healthcare, be it through catalysing implementation of the NHS Vaccination Strategy, sharing good practice, or encouraging innovative ways of purchasing antibiotics to tackle the global threat of antimicrobial resistance. We recognise that we have an important part to play and know that we cannot achieve our purpose alone. Effective partnerships and collaborations are critical to fuelling innovation! #HealthcareInnovation ·      Intergenerational teams bring a powerful blend of experience, fresh perspectives, and diverse skill sets. The wonderful Kate Richardson-Walsh OLY OBE shared how her Olympic hockey team came together to win bronze at the London Olympics in 2012 and finally gold at Rio 2016. A major component for success was that every member of the team felt a sense of belief and belonging. We work every day to cultivate an environment, so that everyone brings their best selves to work and allows us to solve the big issues together, including reducing the inequities that exist across vaccination coverage rates to meet the public health ambition. ·      Executional excellence is a team game - Trusting in each other creates fertile ground for innovation, collaboration, and a thriving work environment. From meticulous planning to flawless implementation, I’m proud to be part of a team that consistently delivers outstanding outcomes. #TeamSuccess I am so excited to work with our wonderful team in this exciting space #msdintheuk

💥 New #SciComm article alert! In this new American Society for Microbiology article, Dr. Rodney E Rohde, SV, SM, MB (ASCP), FACSc, and I work through the history and progress of polio through a certain lens: global hope. The story of polio through time presents us with multiple examples of what can come from innovation, collaboration, equitable distribution of vaccines, and community. It is my truest hope that we can continuously learn from history and leverage this knowledge to come together for better public health. https://lnkd.in/gpX3wYYT